Published in Health Risk Factor Week, February 20th, 2007
This trend article about University of Montreal, Canada, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Data detailed in "Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels" have been presented. According to a study from Canada, "Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the mammalian brain. It acts via both ionotropic GABA-A and metabotropic GABA-B receptors."
"We evaluated the interaction of receptors with members of the inwardly rectifying potassium (Kir...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.